Back to search

Switzerland· 38077001

Prontolax, Suppositorien

A bisacodyl product, registered in Switzerland by Streuli Pharma AG and dispensed under Swissmedic category B/D. The same ATC class is registered in 15 of our 19 countries.

Cat B/D (Swissmedic)ATC A06AB02

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedProntolax, SuppositorienATCA06AB02REGISTER NO.38077001PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Bisacodyl is registered in 15 of 19 countries.

Countries holding a registration under ATC A06AB02 (bisacodyl), each read from that country’s own register.

  • This record: Switzerland
  • 8 of them publish a price we can compare per daily dose

Bisacodyl · ATC A06AB02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bisacodyl costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.088 in United States to $0.72 in Switzerland — a ×8.2 gap.

  • Switzerland: $0.72 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Bisacodyl · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.72
  • US United States$0.088 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Manufacturer
Streuli Pharma AG
Country
Switzerland (CH)
ATC code
A06AB02
ATC class
Bisacodyl
Defined daily dose
10 mg, O
Swissmedic category
B/D
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

263 interactions on record for bisacodyl.

Graded by severity as the source publishes them — 262 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bisacodyl · interactions on record

263 records

  • 262 moderate
  • 1 minor

Most severe, free to view

  • Magnesium carbonateA02AA01moderate
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Calcium carbonateA02AC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e178b81f-02a3-4f27-9e95-058eb3e16752
GET /v1/drugs/e178b81f-02a3-4f27-9e95-058eb3e16752?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about bisacodyl.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.